Variant report

Variant	esv3482023
Chromosome Location	chr9:16882424-16885112
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 141 )
Associated
traits (count: 82 )

Variant overlapped rSNPs/rCNVs (count:141 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs199538349	chr9:16882444-16882445	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs546702085	chr9:16882445-16882446	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs373445455	chr9:16882460-16882461	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs137966645	chr9:16882467-16882468	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs372115563	chr9:16882468-16882469	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs536165912	chr9:16882481-16882482	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs554703733	chr9:16882486-16882487	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs538297245	chr9:16882500-16882501	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs566375733	chr9:16882509-16882510	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs386733153	chr9:16882512-16882513	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs536740498	chr9:16882513-16882514	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs549892996	chr9:16882515-16882516	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs558264995	chr9:16882523-16882524	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs576408344	chr9:16882533-16882534	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs540992678	chr9:16882537-16882538	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs552048469	chr9:16882546-16882547	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs149480995	chr9:16882547-16882548	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs571696549	chr9:16882548-16882549	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs542159871	chr9:16882549-16882550	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs112299097	chr9:16882550-16882551	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs531167369	chr9:16882554-16882555	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs114897307	chr9:16882555-16882556	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs532624487	chr9:16882561-16882562	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs373028096	chr9:16882601-16882602	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs183591399	chr9:16882611-16882612	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs547928076	chr9:16882612-16882613	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs4330781	chr9:16882634-16882635	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs557975943	chr9:16882709-16882710	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs568366527	chr9:16882710-16882711	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs575842493	chr9:16882711-16882712	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs376145646	chr9:16882761-16882762	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs529999081	chr9:16882763-16882764	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs548119922	chr9:16882780-16882781	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs188285124	chr9:16882819-16882820	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs115541690	chr9:16882831-16882832	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs141159864	chr9:16882834-16882835	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs79996576	chr9:16882843-16882844	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs146145815	chr9:16882858-16882859	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs35972588	chr9:16882888-16882889	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs558182866	chr9:16882889-16882890	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs398010382	chr9:16882899-16882900	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs4644350	chr9:16882916-16882917	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs552885451	chr9:16882928-16882929	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs181106650	chr9:16882976-16882977	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs542498272	chr9:16882982-16882983	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs557718047	chr9:16883006-16883007	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs184843438	chr9:16883007-16883008	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs565484960	chr9:16883026-16883027	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs577346076	chr9:16883043-16883044	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs142103429	chr9:16883093-16883094	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:82)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21611746	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:49 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:16872000-16885000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr9:16874000-16883400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr9:16879200-16883600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
4	chr9:16879600-16883800	Weak transcription	NHLF	lung
5	chr9:16880000-16883600	Weak transcription	Dnd41	blood
6	chr9:16880400-16883200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
7	chr9:16881000-16883200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr9:16881000-16883400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr9:16883200-16884400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr9:16883200-16885400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
11	chr9:16883200-16886200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
12	chr9:16883400-16884400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr9:16883400-16885400	Enhancers	Osteobl	bone
14	chr9:16883400-16886000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr9:16883600-16885800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
16	chr9:16883600-16886600	Enhancers	Dnd41	blood
17	chr9:16883800-16885400	Enhancers	Fetal Lung	lung
18	chr9:16883800-16885400	Enhancers	Stomach Smooth Muscle	stomach
19	chr9:16883800-16885800	Enhancers	HSMM	muscle
20	chr9:16883800-16885800	Enhancers	NHDF-Ad	bronchial
21	chr9:16883800-16886000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
22	chr9:16883800-16886000	Enhancers	NHLF	lung
23	chr9:16883800-16886200	Enhancers	Primary hematopoietic stem cells	blood
24	chr9:16883800-16886200	Enhancers	Primary hematopoietic stem cells short term culture	blood
25	chr9:16884000-16886200	Enhancers	Primary monocytes fromperipheralblood	blood
26	chr9:16884200-16884600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
27	chr9:16884200-16885600	Enhancers	Monocytes-CD14+_RO01746	blood
28	chr9:16884400-16884600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
29	chr9:16884400-16884800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr9:16884400-16885000	Enhancers	HSMMtube	muscle
31	chr9:16884400-16885200	Enhancers	Rectal Smooth Muscle	rectum
32	chr9:16884400-16885600	Enhancers	Muscle Satellite Cultured Cells	--
33	chr9:16884400-16886000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr9:16884600-16884800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr9:16884600-16885000	Enhancers	Adipose Nuclei	Adipose
36	chr9:16884600-16885400	Enhancers	Colon Smooth Muscle	Colon
37	chr9:16884800-16885000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr9:16884800-16885200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr9:16884800-16885200	Enhancers	Placenta	Placenta
40	chr9:16884800-16885400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
41	chr9:16884800-16885600	Enhancers	Primary neutrophils fromperipheralblood	blood
42	chr9:16885000-16885400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr9:16885000-16885400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr9:16885000-16885400	Enhancers	Primary T cells from cord blood	blood
45	chr9:16885000-16885400	Weak transcription	HSMMtube	muscle
46	chr9:16885000-16885600	Enhancers	Fetal Stomach	stomach
47	chr9:16885000-16885800	Enhancers	ES-I3 Cell Line	embryonic stem cell
48	chr9:16885000-16886000	Enhancers	Fetal Thymus	thymus
49	chr9:16885000-16886400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links